Therapeutic cancer vaccine therapy for acute myeloid leukemia.
Immunotherapy
; 13(10): 863-877, 2021 07.
Article
en En
| MEDLINE
| ID: mdl-33955237
Lay abstract Acute myeloid leukemia (AML) is the most common acute leukemia in adults with poor prognosis. Evidence has shown that the immune system can recognize and eradicate AML cells. Immunotherapy, which aims at enhancing this antitumor function, emerges as a powerful cancer therapy. Cancer vaccine, one of the immunotherapies, helps the immune system recognize tumor cells. The treatment strategy has been explored in AML patients throughout the last decades. This review was a brief introduction of the development and design principle of cancer vaccine in AML. Moreover, we also demonstrated recent progress in vaccination combination with other immune therapies.
Palabras clave
Texto completo:
1
Bases de datos:
MEDLINE
Asunto principal:
Leucemia Mieloide Aguda
/
Vacunas contra el Cáncer
/
Inmunoterapia
Límite:
Humans
Idioma:
En
Revista:
Immunotherapy
Asunto de la revista:
ALERGIA E IMUNOLOGIA
/
TERAPEUTICA
Año:
2021
Tipo del documento:
Article
País de afiliación:
China